Squarepoint
CRDF icon

Squarepoint’s Cardiff Oncology CRDF Stock Holding History

Squarepoint’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.7K Buy
+26,356
New +$54.1K ﹤0.01% 4147
2025
Q2 		– Sell
-127,965
Closed -$402K – 4570
2025
Q1 		$402K Buy
+127,965
New +$506K ﹤0.01% 3492
2024
Q3 		– Sell
-18,045
Closed -$40.1K – 4187
2024
Q2 		$40.1K Buy
18,045
+532
+3% +$2K ﹤0.01% 3930
2024
Q1 		$93.5K Buy
+17,513
New +$46.5K ﹤0.01% 3808
2022
Q1 		– Sell
-20,972
Closed -$126K – 2928
2021
Q4 		$126K Buy
+20,972
New +$125K ﹤0.01% 2862

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return